Skip to main content
. 2007 Aug;3(4):425–430.

Figure 2.

Figure 2

Cardiovascular death, myocardial infarction or heart failure by treatment in the VALIANT trial. Reproduced from Pfeffer MA, McMurray JJV, Velazquez EJ, et al. 2003. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both [Erratum in N Engl J Med, 2004. 350:203]. N Engl J Med, 349:1893–906. Copyright © Massachusetts Medical Society. All rights reserved.